Jiang, Dongpeng http://orcid.org/0009-0001-6797-3005
Huang, Haiwen
Qin, Huimin
Tang, Koukou http://orcid.org/0009-0009-7409-3469
Shi, Xiangru http://orcid.org/0009-0004-1798-2626
Zhu, Tingting http://orcid.org/0000-0001-5142-627X
Gao, Yuqing http://orcid.org/0009-0003-2683-3043
Zhang, Ying
Tian, Xiaopeng http://orcid.org/0009-0009-4955-7807
Fu, Jianhong http://orcid.org/0000-0002-9044-024X
Qu, Weiwei http://orcid.org/0009-0008-7488-903X
Cai, Weilan http://orcid.org/0009-0004-0255-2172
Xu, Yang http://orcid.org/0000-0003-4643-2098
Wu, Depei http://orcid.org/0000-0002-6312-3863
Chu, Jianhong http://orcid.org/0000-0003-0738-728X
Article History
Received: 4 May 2022
Accepted: 7 June 2023
First Online: 20 June 2023
Competing interests
: J.C., D.W., Y.X., T.Z. and D.J. hold patents and/or patent applications in the fields of cancer immunotherapy. The remaining authors declare no competing interests.